Poster Session II (continued)

Programm

• • Poster presentation
  • P062

  CD8+ T cell recognition of cyst-derived antigen during chronic CNS infection with Toxoplasma gondii

  • Molly Bunkofske (Philadelphia, PA / US)

   Immunology of Acute & Chronic Infection
• • Poster presentation
  • P064

  Innovative Assay Development and Targeted Screening Unveil Compounds Against Toxoplasma gondii Bradyzoite and Tachyzoite Forms

  • Taher Uddin (Missouri / US)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P066

  Imiquimod Treatment targets Chronic Toxoplasmosis and its Associated Neurological Complications in a Rat Model

  • Dr. Hiba El Hajj (Beirut / LB)

   Immunology of Acute & Chronic Infection
• • Poster presentation
  • P068

  Evaluation of the Trithiolato-Bridged Arene Ruthenium Complex Conjugated to 9-(2-hydroxyethyl)-Adenine (OD62-18) as a Potential Treatment for Toxoplasma gondii Infection.

  • Kai Pascal Alexander Hänggeli (Bern / CH)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P070

  The IRE1 pathway of the UPR regulates cDC1 function during acute T. gondii infection

  • Lola Gurgoglione (Lille / FR)

   Immunology of Acute & Chronic Infection
• • Poster presentation
  • P072

  PDL1 in ocular toxoplasmosis: Bridging inflammation and immune regulation

  • Benjamin Geiller (Strasbourg / FR)

   Immunology of Acute & Chronic Infection
• • Poster presentation
  • P074

  MQ-1: A Promising Marinoquinoline Derivative Demonstrating Effectiveness in Treating Acute and Chronic Toxoplasmosis in Murine Models

  • Professor Juliana Quero Reimão (Jundiaí / BR)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P076

  Identifying genes associated with acute lethality in Toxoplasma

  • Dr. Eden Yifrach (Cambridge / US)

   Cell Biology
• • Poster presentation
  • P078

  Elucidating the role of a mitochondrial superoxide dismutase in Toxoplasma gondii

  • Dr. Rosa Andrade (Irvine / US)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P080

  Short-term in vitro culture adaptation of Toxoplasma gondii archetypal II and III field isolates induces relevant changes in the transcriptomic profile

  • Professor Rafael Calero-Bernal (Madrid / ES)

   Stage Conversion & Developmental Biology
• • Poster presentation
  • P082

  Uncovering the role of DEAD-box RNA helicase TgmRHel1 in mitochondrial gene expression

  • Zala Gluhic (Berlin / DE)

   Cell Biology
• • Poster presentation
  • P084

  IFN-gamma production by brain-resident cells activates cerebral mRNA expression of a wide spectrum of molecules critical for both innate and T cell-mediated protective immunity to control reactivation of chronic infection with Toxoplasma gondii

  • Professor Yasuhiro Suzuki (Lexington, KY / US)

   Immunology of Acute & Chronic Infection
• • Poster presentation
  • P086

  Unraveling the role of IL-36γ in host susceptibility during Toxoplasma gondii infection

  • Jessica Belmares-Ortega (Albuquerque / US)

   Cell Biology
• • Poster presentation
  • P088

  Estimating Toxoplasma gondii seroprevalence in wild boars (Sus scrofa) hunted in Ukraine, using three serological methods

  • Dr. Maryna Galat (Bern / CH)

   Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
• • Poster presentation
  • P090

  In vitro production of cat-restricted Toxoplasma pre-sexual stages by epigenetic reprogramming

  • Martina Shahinas (La Tronche / FR)

   Stage Conversion & Developmental Biology
• • Poster presentation
  • P092

  Serological determination of Toxoplasma gondii infection in sheep and molecular detection of Toxoplasma gondii in ovine aborted fetus in Gilan province, North of Iran.

  • Dr. Mohammad Reza Chaechi Nosrati (Lahijan / IR)

   Genomics
• • Poster presentation
  • P094

  Exploring the Role of PCKMT in the Gliding Initiation Complex: Implications for Toxoplasma gondii Infectivity and Motility

  • Dr. Elena Jimenez-Ruiz (Munich / DE)

   Cell Biology
• • Poster presentation
  • P098

  Elucidating the Role of CST in Cyst Wall Structure and Integrity

  • Dr. Tadikimi Tomita (Bronx / US)

   Stage Conversion & Developmental Biology
• • Poster presentation
  • P100

  Deciphering the host defence mechanisms targeting Toxoplasma in retinal epithelial cells

  • Dr. Barbara Clough (Birmingham / GB)

   Innate Immunity and Immune Evasion
• • Poster presentation
  • P102

  Expansion of Toxoplasma gondii cysts in vitro using enzymatically enhanced ultrastructure expansion microscopy

  • Dr. Kseniia Bondarenko (Edinburgh / GB)

   Cell Biology
• • Poster presentation
  • P104

  Reinvention of the diagnostic algorithm and treatment options for reactivated toxoplasmosis – ToxoReTREAT project

  • Dr. Tijana Štajner (Belgrade / RS)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P106

  Single-RNA sequencing analysis of merozoite stages of Toxoplasma gondii in the intestine of cats

  • Zixuan Wang (Beijing / CN)

   Stage Conversion & Developmental Biology
• • Poster presentation
  • P108

  Searching for a vaccine against toxoplasmosis

  • Carina Brito (Porto / PT)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P110

  Expression of the pro-apoptotic proteins Bak and Bax during in-vitro infection of murine cells with Toxoplasma gondii Tachyzoites

  • Dr. Zaida Rentería-Solís (Leipzig / DE)

   Intracellular Replication & Survival
• • Poster presentation
  • P112

  Compounds From the MMV Pathogen Box Target Toxoplasma gondii Tachyzoites and Bradyzoites: Insights into Metabolic Responses and the Role of the bc₁-Complex in Bradyzoites

  • Deborah Maus (Berlin / DE)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P114

  The myxobacterial compound Argyrin D inhibits protein translation in the mitochondria of Toxoplasma gondii and arrests tachyzoites and bradyzoites.

  • Janina Jocks (Berlin / DE)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P116

  Differential Gene Expression of Toxoplasma gondii ME49 and RH Strains during ELQ-316 Inhibition

  • Jon deVries (Portland / US)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P118

  The Role of Polyphosphates in Toxoplasma gondii

  • Juan Camilo Arenas Garcia (Athens / US)

   Cell Biology
• • Poster presentation
  • P120

  Investigating the role of the residual body in cytoskeletal turnover during Toxoplasma replication

  • William O'Shaughnessy (Dallas / US)

   Cell Biology
• • Poster presentation
  • P122

  CD4+ T Cell Responses to Toxoplasma gondii Are a Double-Edged Sword

  • Professor Rima McLeod (Chicago / US)

   Immunology of Acute & Chronic Infection